Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60fbefc3a0010b6c33e93beec1be7ceb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate |
2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a70f8a8e01e7d62d4b52ff79c7910a |
publicationDate |
2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022235622-A2 |
titleOfInvention |
Cd20 targeting fusion proteins and methods of use thereof |
abstract |
Provided herein are fusion proteins comprising a CD20 targeting domain and an effector domain, wherein the effector domain comprises IL-2. Also provided herein are methods of treating cancer in a subject by administering a fusion protein comprising a CD20 targeting domain and an effector domain, wherein the effector domain comprises IL-2. |
priorityDate |
2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |